{"id": "1386847566759972870", "creation": 1619485200.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 0, "like_count": 1, "quote_count": 1}}, "text": "#Sinopharm, the Chinese pharmaceutical giant, has commenced phase-1 and phase-2 clinical trials for its new recombinant #vaccine against #COVID19 in Henan Province since Apr. 24. It was developed by the China National Biotec Group (#CNBG), a Sinopharm's bioscience subsidiary. https://t.co/sTQx4gpGxv", "first_save": 1634559108.199414, "hashtags": ["#SINOPHARM", "#VACCINE", "#COVID19", "#CNBG"]}